Article
Published 9 Oct 2024
A New 2024 Code For The British Pharmaceutical Industry – "The Future Is Orange"
Arnold & Porter
Your search return 5,607 results
Refine Your Search
Search Results
- Relevance
- Newest
- Oldest
Article
Published 9 Oct 2024
Developing An Effective Patenting Policy To Protect AI-Enabled Medical Devices
Marshall, Gerstein & Borun LLP
Article
Published 8 Oct 2024
EMA Adopts Reflection Paper On The Use Of Artificial Intelligence (AI)
Arnold & Porter
Article
Published 8 Oct 2024
NORD Annual Breakthrough Summit
Goodwin Procter LLP
Article
Published 7 Oct 2024
Royalty Monetizations: The "What, Why, When, Who And How" For Universities, Non-Profit Institutions And Life Sciences Companies
Foley Hoag LLP
Article
Published 7 Oct 2024
Express Scripts Sues FTC Over Report On Pharmacy Benefit Management Industry
Goodwin Procter LLP
Article
Published 4 Oct 2024
FDA Removes Certain Peptide Bulk Drug Substances From Category 2 Of Interim 503A Bulks List And Sets Dates For PCAC Review
Reed Smith
Article
Published 4 Oct 2024
Myrbetriq® Patent Invalidated On Grounds Not Asserted By Any Party Violating Party Presentation Principle
Oblon, McClelland, Maier & Neustadt, L.L.P
Article
Published 3 Oct 2024
Implications Of FDA's Stem Cell Win In The 9th Circuit
Buchanan Ingersoll & Rooney PC
Article
Published 2 Oct 2024
House Of Representatives Passes BIOSECURE Act
Baker Botts
Article
Published 2 Oct 2024
California Pharmacies Put On Notice: California's Pharmacy Transaction Notice Requirement
BakerHostetler
Article
Published 2 Oct 2024
Decentralized Clinical Trials: Research Misconduct Risks & How To Avoid Them
Foley & Lardner
Article
Published 1 Oct 2024
Biosecure Act: Recharting The Map Of Biopharma Manufacturing
Alvarez & Marsal
Article
Published 30 Sep 2024
Three Of A Kind: FDA Guidance Documents Provide Recommendations On Non-Traditional Clinical Trial Designs
Ropes & Gray LLP
Article
Published 27 Sep 2024
U.S. House Of Representatives Pass BIOSECURE, Cloud Access And Multiple Other Bills Targeting China
Simpson Thacher & Bartlett
Article
Published 27 Sep 2024
BIOSECURE Act: US To Target Chinese Biotechnology Companies
McDermott Will & Emery
Article
Published 27 Sep 2024
Fireside Chat With Co-Chairs Of The Hispanic National Bar Association's Health & Life Sciences Section (Podcast)
Reed Smith
Article
Published 27 Sep 2024
The Necessity Of Implementing An Information Governance Program
Butler Snow LLP
Article
Published 27 Sep 2024
BIOSECURE Act Timeline
Goodwin Procter LLP
Article
Published 26 Sep 2024
This Week In 340B: September 17 – 23, 2024
McDermott Will & Emery